Hangzhou Tigermed Consulting (03347) intends to repurchase the company's A-shares.
Tage Pharmaceuticals (03347) has announced that the company plans to repurchase some of its A shares through centralized bidding trading using its own funds or self-raised funds, for the purpose of implementing A-share equity incentive plans or A-share employee stock ownership plans, as well as reducing the company's registered capital. The total amount of repurchase funds will be no less than 500 million yuan and no more than 1 billion yuan.
Hangzhou Tigermed Consulting (03347) announced that the company plans to repurchase some of its A shares through centralized competitive trading using its own funds or self-raised funds. The purpose of the repurchase is to implement an A-share equity incentive plan or an A-share employee stock ownership plan, as well as to reduce the company's registered capital. The total amount of repurchase funds will be no less than RMB 500 million and no more than RMB 1 billion.
Related Articles
US Stock Market Move | Ford Motor Company (F.US) rose more than 8% as it enters the large-scale energy storage market with Contemporary Amperex Technology technology.
In the AI era, the technology industry continues to lay off employees. Microsoft Corporation's (MSFT.US) subsidiary LinkedIn has initiated a new round of personnel adjustments.
KANGLI INT HLDG (06890): Qu Xuanhua appointed as Independent Non-Executive Director.
US Stock Market Move | Ford Motor Company (F.US) rose more than 8% as it enters the large-scale energy storage market with Contemporary Amperex Technology technology.
In the AI era, the technology industry continues to lay off employees. Microsoft Corporation's (MSFT.US) subsidiary LinkedIn has initiated a new round of personnel adjustments.
KANGLI INT HLDG (06890): Qu Xuanhua appointed as Independent Non-Executive Director.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
